nialamide has been researched along with Dermatitis, Atopic in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| NARANJO, P | 1 |
| HEIM, E | 1 |
| KONZELMANN, M | 1 |
| STORCK, H | 1 |
2 other studies available for nialamide and Dermatitis, Atopic
| Article | Year |
|---|---|
[Nialamide as a coadjuvant in the treatment of allergic eczema].
Topics: Dermatitis, Atopic; Eczema; Iproniazid; Nialamide | 1961 |
[The influence of niamid on the autonomic circulation in patients with atopic eczema].
Topics: Autonomic Nervous System; Biological Phenomena; Blood Circulation; Dermatitis, Atopic; Eczema; Ipron | 1961 |